---
$id: https://graph.org.ai/products/commodity/51111850
$type: Product
source: UNSPSC
code: "51111850"
title: "Gonadorelin"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Gonadorelin

**UNSPSC Code**: 51111850
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a gnrh1 gene with the molecular formula C55H75N17O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9O7312W37G, chemically known as gonadotropin, luteinizing hormone-releasing hormone, synthetic but generally known as gonadorelin, which bears US NIH Compound Identifier 36523. European Medicines Agency schedules Gonadorelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07960MIG. The term GONADORELIN is an International Non-Proprietary Name. World Health Organization schedules gonadorelin in its Anatomical Therapeutic Chemical (ATC) Classification. GONADORELIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule gonadorelin under HS 29371900 and SITC 54154. As of Q4 2014, GONADORELIN remains the US FDA Preferred Term for this commodity. SMILES: O=C(N1C(CCC1)C(=O)NCC(=O)N)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C1NC(=O)CC1)CC1[NH]CNC1)CC1C2C([NH]C1)CCCC2)CO)CC1CCC(O)CC1)CC(C)C)CCC/N=C(/N)N.

